Stock screenerAll disclosures →
EDGAR →
NRIX
Conviction 60HealthcareScan · Thu, Sep 24, 2026Dragonfly doji
Nurix Therapeutics, Inc. (NRIX) closed at $23.67 (-0.88%) on Sep 24, 2026. Its latest daily candle is a dragonfly doji. Price is below its 50-day and above its 200-day moving average. RSI(14) 36, RS Rating 98, -14.8% from its 52-week high, +31.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
NRIX$23.67-0.88%
ResistanceSupportVol 14Insider sell2
2
Vol MA14 1.44M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price23.67
Change-0.88%
Gap-0.90%
Rel volume1.30×
Avg volume1.42M
Avg $ vol36.14M
SMA 2025.53
SMA 5025.27
SMA 20019.48
Price vs 50-6.35%
Price vs 200+21.53%
MA stackmixed
50/200 cross—
Supertrenddown · 26.60
RSI (14)36
MACD hist-0.25
MACD cross—
Stoch %K / %D18 / 24
ADX (14)21
+DI / −DI18 / 27
RSI divergence—
MACD divergenceBullish
ATR %4.44%
ADR %4.06%
52w high27.79
52w low8.33
From 52w high-14.83%
Above 52w low+184.15%
New 52w highNo
SqueezeFired
Bollinger width11.68%
%B-0.12
Donchian pos14.89%
Donchian high27.50
Donchian low23.00
AVWAP (52w high)25.84
vs AVWAP high-8.39%
AVWAP (52w low)17.80
vs AVWAP low+32.98%
OBV trendDown
Chaikin MF (20)-0.02
Today vs 20d1.30×
Avg vol (14d)1.44M
Avg vol (20d)1.42M
Avg $ vol (20d)36.14M
Market cap2.46B
RS Rating98 / 99
RS 3m (vs SPY)+0.90%
RS 6m (vs SPY)+36.49%
RS line new highNo
Trend template7/8
Technical rank64.2
1 week-7.18%
1 month-12.17%
3 months+5.39%
6 months+53.30%
1 year+187.26%
YTD+31.06%
P/E-9.29
P/B6.10
P/S29.25
P/FCF-9.32
EPS-3.05
Div yield—
ROE-65.68%
ROA-49.38%
Debt/Eq—
Current6.34
EV/EBITDA-8.63
Gross margin—
Net margin-314.90%
Rev growth53.95%
EPS growth-36.62%
Price target34.27
Target upside44.78%
Analyst ratingBuy
Institutional119.04%
Ent. value2.39B
Revenue9.04M
Net income-89.53M
Gross profit—
Free cash flow-263.47M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out103.41M
Employees357
ListedFri, Jul 24, 2020
Free float97.8M
Float %94.6%
Short interest17.95M
Days to cover15.9d
Short volume36.1%
Squeeze score66 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.81 vs −$0.73
Last surprise-11.0% miss
Setup gradeB
Conviction60 / 100
Pattern quality—
Tech rank64.2 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmDragonfly doji
Financials as of Sun, May 31, 2026 · quarterly.
Recent news
- More than 5% of Nurix Therapeutics (NRIX) is reported by three parties, but one fund holds the shares.Stock Titan · Wed, Sep 23, 2026
- Nurix Therapeutics, Inc.: Passive 5% stake disclosedSEC EDGAR · Wed, Sep 23, 2026
- Trading Systems Reacting to (NRIX) VolatilityStock Traders Daily · Tue, Sep 22, 2026
Congress activity
Disclosed STOCK Act trades in NRIX
No recent disclosed trades by Congress in NRIX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NRIX · open-market 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ring Christine Chief Legal Officer · Common Stock · 2026-09-02 | Exercise | 5.79K | $50K | 2026-09-02 | 2026-09-02 |
Ring Christine Chief Legal Officer · Common Stock · 2026-09-02 | Sell | 5.39K | $138K | 2026-09-02 | 2026-09-02 |
Ring Christine Chief Legal Officer · Common Stock · 2026-09-02 | Sell | 400 | $11K | 2026-09-02 | 2026-09-02 |
Ring Christine Chief Legal Officer · Employee Stock Option (right to buy) · 2026-09-02 | Exercise | 5.79K | — | 2026-09-02 | 2026-09-02 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-05 | Sell | 4.36K | $109K | 2026-08-05 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-05 | Exercise | 4.36K | $8K | 2026-08-05 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Employee Stock Option (right to buy) · 2026-08-05 | Exercise | 4.36K | — | 2026-08-05 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-04 | Sell | 2.61K | $64K | 2026-08-04 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-08-04 | Sell | 1.5K | $36K | 2026-08-04 | 2026-08-05 |
Hansen Gwenn Chief Scientific Officer · Common Stock · 2026-06-25 | Sell | 5.39K | $108K | 2026-06-25 | 2026-06-25 |
SEC filings
EDGAR filings in NRIX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.